NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
Back to search
Official data from USPTO
CANCERVAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
04/02/2024
Trademark type
Word
Nice classes
42
Filing date
06/03/2021
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
04/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
First use anywhere
05/26/2021
First use in commerce
05/26/2021
Drawing code
4
Owner type
03
Owner location
Santa Barbara, CA, US
Examiner
SABAGH, LAILA TAREK
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CancerVAX, Inc.
Representatives
DANIEL C NEUSTADT HOLLAND & KNIGHT LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of vaccines and medications for cancer
Publications
History of USPTO decisions and trademark events.
28 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
04/02/2024
EXPT
EXPARTE APPEAL TERMINATED
02/22/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
02/22/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
08/21/2023
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
06/16/2023
GECD
ACTION DENYING REQ FOR RECON E-MAILED
06/16/2023
CNCF
ACTION CONTINUING FINAL - COMPLETED
06/16/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/27/2023
EXPI
EX PARTE APPEAL-INSTITUTED
03/27/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
03/27/2023
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
03/27/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/07/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
03/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/07/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/27/2022
GNFR
FINAL REFUSAL E-MAILED
09/27/2022
CNFR
FINAL REFUSAL WRITTEN
09/27/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/19/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/18/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/18/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/18/2022
GNRT
NON-FINAL ACTION E-MAILED
02/18/2022
CNRT
NON-FINAL ACTION WRITTEN
02/18/2022
DOCK
ASSIGNED TO EXAMINER
02/17/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/26/2021
NWAP
NEW APPLICATION ENTERED
06/07/2021
Continuous trademark protection
Get notified about every new filing that threatens CANCERVAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.